Literature DB >> 7095333

Metabolic control and serum hormone levels in relation to retinopathy in diabetic pregnancy.

J Larinkari, L Laatikainen, T Ranta, P Mörönen, K Pesonen, T Laatikainen.   

Abstract

The occurrence and progression of retinopathy were related to the mean blood glucose levels and the serum concentrations of prolactin, human placental lactogen, oestradiol and progesterone in 57 pregnant insulin-dependent diabetic patients. Fifteen patients had frank retinopathy, of whom eight showed a marked increase in retinopathy. The initial blood glucose levels were significantly higher in patients whose retinopathy progressed, whereas during the second and third trimester similar blood glucose levels were achieved in all groups. Serum concentrations of progesterone and human placental lactogen were significantly increased in diabetic patients during the last trimester when compared with those in normal pregnancies, and during the second trimester, patients with retinopathy showed significantly higher concentrations than those without, but no significant difference was found in oestradiol values. The eight patients with progressive retinopathy showed progesterone, human placental lactogen and oestradiol levels at or above the upper limit of the normal range. Throughout gestation, serum prolactin concentrations were significantly lower in diabetic patients than in healthy subjects. No correlation was found between serum prolactin values and the occurrence of retinopathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7095333     DOI: 10.1007/BF00253576

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  [Not Available].

Authors:  H JANERT; G MOHNIKE; P GEORGI
Journal:  Klin Wochenschr       Date:  1957-02-01

2.  The precision of percentiles in establishing normal limits in medicine.

Authors:  L HERRERA
Journal:  J Lab Clin Med       Date:  1958-07

3.  Effects of fetal sex and weight and placental weight on maternal serum progesterone and chorionic gonadotropin concentrations.

Authors:  W N Spellacy; P W Conly; W W Cleveland; W S Buhi
Journal:  Am J Obstet Gynecol       Date:  1975-06-01       Impact factor: 8.661

4.  Serum prolactin in normal and pathologic pregnancy.

Authors:  E Sadovsky; D Weinstein; M Ben-David; W Z Polishuk
Journal:  Obstet Gynecol       Date:  1977-11       Impact factor: 7.661

5.  Patterns of serum immunoreactive human placental lactogen (IR-HPL) and chorionic gonadotropin (IR-HCG) in diabetic pregnancy.

Authors:  H A Selenkow; K Varma; D Younger; P White; K Emerson
Journal:  Diabetes       Date:  1971-10       Impact factor: 9.461

6.  Raised serum prolactin levels in amenorrhoea.

Authors:  M Seppălă; E Hibroven; T Ranta; P Virkkunen; J Leppăluoto
Journal:  Br Med J       Date:  1975-05-10

7.  Diabetic retinopathy and prolactin.

Authors:  A Froland; C Hagen; E Lauritzen
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

Review 8.  Banting Lecture 1980. Of pregnancy and progeny.

Authors:  N Freinkel
Journal:  Diabetes       Date:  1980-12       Impact factor: 9.461

9.  Plasma concentrations of unconjugated estrone, estradiol-17beta and estriol, and HCS throughout pregnancy in diabetics and gestational diabetics.

Authors:  R De Hertogh; K Thomas; J J Hoet; I Vanderheyden
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

10.  Diabetes mellitus and pregnancy--management and results at Rikshospitalet, Oslo, 1970-1977.

Authors:  J Jervell; N Moe; J Skjaeraasen; W Blystad; K Egge
Journal:  Diabetologia       Date:  1979-03       Impact factor: 10.122

View more
  6 in total

Review 1.  Diabetic retinopathy and pregnancy.

Authors:  Nicola Pescosolido; Orazio Campagna; Andrea Barbato
Journal:  Int Ophthalmol       Date:  2014-01-31       Impact factor: 2.031

2.  High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins.

Authors:  Edith Arnold; José C Rivera; Stéphanie Thebault; Daniel Moreno-Páramo; Hugo Quiroz-Mercado; Andrés Quintanar-Stéphano; Nadine Binart; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

3.  The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration.

Authors:  Edith Arnold; Stéphanie Thebault; German Baeza-Cruz; David Arredondo Zamarripa; Norma Adán; Andrés Quintanar-Stéphano; Miguel Condés-Lara; Gerardo Rojas-Piloni; Nadine Binart; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

Review 4.  Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives.

Authors:  Rafał Sibiak; Maurycy Jankowski; Paweł Gutaj; Paul Mozdziak; Bartosz Kempisty; Ewa Wender-Ożegowska
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

Review 5.  Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.

Authors:  Jakob Triebel; Thomas Bertsch; Carmen Clapp
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

6.  Relationship between Size of the Foveal Avascular Zone and Carbohydrate Metabolic Disorders during Pregnancy.

Authors:  Masahiko Sugimoto; Yasuko Wakamatsu; Ryohei Miyata; Hisashi Matsubara; Mineo Kondo; Yuki Kamimoto; Tomoaki Ikeda
Journal:  Biomed Res Int       Date:  2019-11-04       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.